Skip to main content

Life sciences organizations face pipeline and productivity challenges, changing regulatory burdens, and timeline erosion from discovery to regulatory approvals. These organizations are forced to develop new business models to compete more effectively, fuel innovation in R&D and drive greater discovery productivity. IBM enables clients to transform the development and delivery of safe, effective diagnostics, drugs and medical devices.

Organizations of all sizes are turning to technical computing solutions for 3-D modeling, simulations and large-scale data analytics with help from IBM.

October 2012 | PDF | 2 MB
Healthcare organizations need to determine what values they will address and develop new competencies to evolve into outcomes-based, performance-driven organizations. Success requires better insight into areas such as clinical performance, patient ...

July 2012 | PDF | 763 KB
Pharmaceutical companies rely on technology, data and their customer base to create higher value and influence opportunities. Clinical content and predictive analytics help optimize decision making and deliver drugs to market faster.

November 2010 | PDF | 227 KB

Adobe Acrobat ReaderPDF files require Adobe® Reader®